FDA Inspection 1204190 — Bertrand Arnulf, MD, PhD
The FDA completed an inspection of Bertrand Arnulf, MD, PhD on April 7, 2023 in Claude Vellefaux. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 7, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Claude Vellefaux (France)
Additional Details
Clinical Investigator (CI)